You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美单日新增22万宗确诊 美政府预备分发首批290万剂辉瑞疫苗
阿思达克 12-10 16:00
美国新冠疫情持续。据美国约翰霍普金斯大学统计,截至美国西岸时间午夜,即本港时间下午4时,美国累计新冠确诊15,391,700宗,单日新增220,024宗。累计新冠死亡个案289,431宗,单日新增3,124宗。

美各州疫情方面,德克萨斯州及加州各录得136万及145.41万宗确诊,佛罗里达州录得108.34万宗确诊,伊利诺伊州及纽约州各录得81.24万及73.31万宗确诊,乔治亚州及俄亥俄州各录51.78万及52.01万宗。

宾夕凡尼亚州长Tom Wolf确诊新冠,正在家居隔离,但未有病徵。另外,美国联邦政府预备在辉瑞(PFE.US)疫苗获美国食品及药物管理局(FDA)批准应用後,分发290万剂辉瑞疫苗,并保留290万剂作第二剂注射,与及50万剂作应急用途。美国国防部会获发当中4.4万剂。

美国过去七日每日新冠疫情统计:

日期│累计确诊│单日新增确诊│累计死亡│单日新增死亡

12月9日(三)│15,391,700宗│+220,024宗│289,431宗│+3,124宗

12月8日(二)│15,171,676宗│+217,344宗│286,307宗│+2,564宗

12月7日(一)│14,954,332宗│+193,706宗│283,743宗│+1,431宗

12月6日(日)│14,760,626宗│+177,060宗│282,312宗│+1,113宗

12月5日(六)│14,583,566宗│+211,933宗│281,199宗│+2,203宗

12月4日(五)│14,371,633宗│+227,832宗(纪录新高)│278,996宗│+2,630宗

12月3日(四)│14,143,801宗│+218,845宗│276,366宗│+2,531宗

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account